Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (5): 520-525.doi: 10.19982/j.issn.1000-6621.20220516
• Review Articles • Previous Articles Next Articles
Yang Jun1, Deng Qiang2(), Peng Randong3, Li Junjie4, Wang Yurong5, Yang Haiyun1, Du Jianqiang1
Received:
2023-01-09
Online:
2023-05-10
Published:
2023-04-25
Contact:
Deng Qiang
E-mail:znzsjzez@163.com
Supported by:
CLC Number:
Yang Jun, Deng Qiang, Peng Randong, Li Junjie, Wang Yurong, Yang Haiyun, Du Jianqiang. Establishment and research progress of rabbit model of spinal tuberculosis[J]. Chinese Journal of Antituberculosis, 2023, 45(5): 520-525. doi: 10.19982/j.issn.1000-6621.20220516
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220516
[1] |
Khanna K, Sabharwal S. Spinal tuberculosis: a comprehensive review for the modern spine surgeon. Spine J, 2019, 19(11):1858-1870. doi:10.1016/j.spinee.2019.05.002.
doi: S1529-9430(19)30171-8 pmid: 31102727 |
[2] |
Tang L, Fu CG, Zhou ZY, et al. Clinical Features and Outcomes of Spinal Tuberculosis in Central China. Infect Drug Resist, 2022, 15:6641-6650. doi:10.2147/IDR.S384442.
doi: 10.2147/IDR.S384442 pmid: 36386413 |
[3] |
高永建, 欧云生, 权正学, 等. 胸腰椎脊柱结核外科治疗的研究进展. 中国修复重建外科杂志, 2018, 32(1):112-117. doi:10.7507/1002-1892.201705124.
doi: 10.7507/1002-1892.201705124 |
[4] |
张中敏, 刘艳芳. 结核分枝杆菌T细胞斑点试验诊断结核性胸膜炎的临床价值. 临床医学研究与实践, 2017, 2(24):45-46. doi:10.19347/j.cnki.2096-1413.201724022.
doi: 10.19347/j.cnki.2096-1413.201724022 |
[5] |
Guo XH, Bai Z, Qiang B, et al. Roles of monocyte chemotactic protein 1 and nuclear factor-kappaB in immune response to spinal tuberculosis in a New Zealand white rabbit model. Braz J Med Biol Res, 2017, 50(3):e5625. doi:10.1590/1414-431X20165625.
doi: 10.1590/1414-431X20165625 URL |
[6] |
Gong W, Liang Y, Wu X. Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis. Biomed Res Int, 2020, 2020:4263079. doi:10.1155/2020/4263079.
doi: 10.1155/2020/4263079 |
[7] |
Zhan L, Tang J, Sun M, et al. Animal Models for Tuberculosis in Translational and Precision Medicine. Front Microbiol, 2017, 8:717. doi:10.3389/fmicb.2017.00717.
doi: 10.3389/fmicb.2017.00717 pmid: 28522990 |
[8] |
Gupta T, Somanna N, Rowe T, et al. Ferrets as a model for tuberculosis transmission. Front Cell Infect Microbiol, 2022, 12:873416. doi:10.3389/fcimb.2022.873416.
doi: 10.3389/fcimb.2022.873416 URL |
[9] |
Creissen E, Izzo L, Dawson C, et al. Guinea Pig Model of Mycobacterium tuberculosis Infection. Curr Protoc, 2021, 1(12):e312. doi:10.1002/cpz1.312.
doi: 10.1002/cpz1.312 |
[10] |
Bucsan AN, Mehra S, Khader SA, et al. The current state of animal models and genomic approaches towards identifying and validating molecular determinants of Mycobacterium tuberculosis infection and tuberculosis disease. Pathog Dis, 2019, 77(4):ftz037. doi:10.1093/femspd/ftz037.
doi: 10.1093/femspd/ftz037 URL |
[11] |
Dannenberg Jr AM. Pathogenesis of pulmonary Mycobacterium bovis infection: basic principles established by the rabbit model. Tuberculosis (Edinb), 2001, 81(1-2):87-96. doi:10.1054/tube.2000.0260.
doi: 10.1054/tube.2000.0260 URL |
[12] |
Dannenberg Jr AM. Liquefaction and cavity formation in pulmonary TB: a simple method in rabbit skin to test inhibitors. Tuberculosis (Edinb), 2009, 89(4):243-247. doi:10.1016/j.tube.2009.05.006.
doi: 10.1016/j.tube.2009.05.006 URL |
[13] |
Manabe YC, Dannenberg AJ, Tyagi SK, et al. Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis. Infect Immun, 2003, 71(10):6004-6011. doi:10.1128/IAI.71.10.6004-6011.2003.
doi: 10.1128/IAI.71.10.6004-6011.2003 URL |
[14] |
Popov BV, Sutula GI, Petrov NS, et al. Preparation and charac-terization of the antibody recognizing AMACR inside its catalytic center. Int J Oncol, 2018, 52(2):547-559. doi:10.3892/ijo.2017.4220.
doi: 10.3892/ijo.2017.4220 |
[15] |
Liu P, Jiang H, Li S, et al. Determination of anti-tuberculosis drug concentration and distribution from sustained release microspheres in the vertebrae of a spinal tuberculosis rabbit model. J Orthop Res, 2017, 35(1):200-208. doi:10.1002/jor.23236.
doi: 10.1002/jor.23236 pmid: 26996958 |
[16] |
Yue X, Zhu X, Wu L, et al. A comparative study of a rabbit spinal tuberculosis model constructed by local direct infection via the posterior lateral approach. Sci Rep, 2022, 12(1):12853. doi:10.1038/s41598-022-16624-2.
doi: 10.1038/s41598-022-16624-2 pmid: 35896778 |
[17] |
乔永杰, 李松凯, 甄平, 等. 不同浓度结核菌建立兔脊柱结核模型的对比研究. 中国矫形外科杂志, 2017, 25(5):459-465. doi:10.3977/j.issn.1005-8478.2017.05.15.
doi: 10.3977/j.issn.1005-8478.2017.05.15 |
[18] |
Geng G, Wang Q, Shi J, et al. Establishment of a New Zea-land Rabbit Model of Spinal Tuberculosis. J Spinal Disord Tech, 2015, 28(3):E140-E145. doi:10.1097/BSD.0000000000000191.
doi: 10.1097/BSD.0000000000000191 URL |
[19] |
涂振阳, 蓝常贡, 谢克恭, 等. 兔结核病模型的应用研究进展. 微生物学杂志, 2019, 39(6):102-108. doi:10.3969/j.issn.1005-7021.2019.06.014.
doi: 10.3969/j.issn.1005-7021.2019.06.014 |
[20] |
Andre E, Isaacs C, Affolabi D, et al. Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination. Int J Tuberc Lung Dis, 2016, 20(8):999-1003. doi:10.5588/ijtld.16.0015.
doi: 10.5588/ijtld.16.0015 pmid: 27393530 |
[21] | 罗飞. 脊柱结核的治疗. 中华骨科杂志, 2014, 34(5):598. |
[22] | 中国防痨协会临床专业委员会. 结核病临床诊治进展年度报告(2011年). 中国防痨杂志, 2012, 34(6):393-403. |
[23] |
侯长浩, 路小欢, 陆雪儿, 等. 新型结核疫苗的研究进展. 中国病原生物学杂志, 2018, 13(8):925-929. doi:10.13350/j.cjpb.180830.
doi: 10.13350/j.cjpb.180830 |
[24] |
Liu X, Jia W, Wang H, et al. Establishment of a rabbit model of spinal tuberculosis using Mycobacterium tuberculosis strain H37Rv. Jpn J Infect Dis, 2015, 68(2):89-97. doi:10.7883/yoken.JJID.2014.147.
doi: 10.7883/yoken.JJID.2014.147 URL |
[25] |
陈振, 吴鹏, 马荣, 等. 构建新西兰兔脊柱结核模型的实验研究. 宁夏医科大学学报, 2015, 37(10):1124-1127. doi:10.16050/j.cnki.issn1674-6309.2015.10.003.
doi: 10.16050/j.cnki.issn1674-6309.2015.10.003 |
[26] | 耿广起. 新西兰兔脊柱结核模型的构建及评价相关实验研究. 银川:宁夏医科大学, 2012. |
[27] |
Liu X, Wang Y, Jia W. Early diagnosis of spinal tuberculosis by magnetic resonance: perfusion weighted imaging in a rabbit model. BMC Med Imaging, 2022, 22(1):142. doi:10.1186/s12880-022-00870-x.
doi: 10.1186/s12880-022-00870-x pmid: 35945512 |
[28] |
蒲育, 环明苍. 脊柱结核并发HIV感染/AIDS患者的诊治现状与进展概述. 中国防痨杂志, 2020, 42(5):428-435. doi:10.3969/j.issn.1000-6621.2020.05.004.
doi: 10.3969/j.issn.1000-6621.2020.05.004 |
[29] |
范顺武, 胡子昂. 重视脊柱结核化学药物治疗的重要性. 中国骨伤, 2017, 30(9):783-786. doi:10.3969/j.issn.1003-0034.2017.09.001.
doi: 10.3969/j.issn.1003-0034.2017.09.001 |
[30] |
Hasenoehrl EJ, Wiggins TJ, Berney M. Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis. Front Cell Infect Microbiol, 2020, 10:611683. doi:10.3389/fcimb.2020.611683.
doi: 10.3389/fcimb.2020.611683 URL |
[31] |
中国防痨协会. 耐药结核病化学治疗指南(2019年简版). 中国防痨杂志, 2019, 41(10):1025-1073. doi:10.3969/j.issn.1000-6621.2019.10.001.
doi: 10.3969/j.issn.1000-6621.2019.10.001 |
[32] |
邓强, 李军杰, 张彦军, 等. 复治脊柱结核规范化治疗的再认识与思考. 兰州大学学报(医学版), 2019, 45(4):54-60. doi:10.13885/j.issn.1000-2812.2019.04.011.
doi: 10.13885/j.issn.1000-2812.2019.04.011 |
[33] |
Wang XW, Liu JJ, Wu QN, et al. The in vitro and in vivo effects of microRNA-133a on intervertebral disc destruction by targeting MMP9 in spinal tuberculosis. Life Sci, 2017, 188:198-205. doi:10.1016/j.lfs.2017.07.022.
doi: 10.1016/j.lfs.2017.07.022 URL |
[34] |
Wang W, Yang B, Cui Y, et al. Isoliquiritigenin attenuates spinal tuberculosis through inhibiting immune response in a New Zealand white rabbit model. Korean J Physiol Pharmacol, 2018, 22(4):369-377. doi:10.4196/kjpp.2018.22(4):369-377.
doi: 10.4196/kjpp.2018.22.4.369 URL |
[35] |
Zhao Y, Jiao Y, Wang L. Hesperidin methyl chalcone alleviates spinal tuberculosis in New Zealand white rabbits by suppressing immune responses. J Spinal Cord Med, 2020, 43(4):532-539. doi:10.1080/10790268.2018.1507805.
doi: 10.1080/10790268.2018.1507805 pmid: 30124375 |
[36] |
周文强, 张爽, 初乃惠. 耐药肺结核全口服治疗方案研究的现状和展望. 中国防痨杂志, 2021, 43(9):879-882. doi:10.3969/j.issn.1000-6621.2021.09.005.
doi: 10.3969/j.issn.1000-6621.2021.09.005 |
[37] |
戈朝晖, 马荣, 陈振, 等. 载异烟肼及利福平白蛋白纳米粒治疗兔脊柱结核的实验观察. 中国脊柱脊髓杂志, 2018, 28(3):253-261. doi:10.3969/j.issn.1004-406X.2018.03.10.
doi: 10.3969/j.issn.1004-406X.2018.03.10 |
[38] |
黄正辉, 刘炜, 王静丽. 脂肪间充质干细胞复合利福平缓释微球在脊柱结核动物模型中的应用. 中国组织工程研究, 2017, 21(26):4192-4198. doi:10.3969/j.issn.2095-4344.2017.26.016.
doi: 10.3969/j.issn.2095-4344.2017.26.016 |
[39] |
Ma R, Zhang J, Chen Z, et al. Treatment of spinal tuberculosis in rabbits using bovine serum albumin nanoparticles loaded with isoniazid and rifampicin. Neurol Res, 2022, 44(3):268-274. doi:10.1080/01616412.2021.1979749.
doi: 10.1080/01616412.2021.1979749 URL |
[40] |
Wang Z, Maimaitiaili A, Wang T, et al. Rifapentine Polylactic Acid Sustained-Release Microsphere Complex for Spinal Tuberculosis Therapy: Preparation, in vitro and in vivo Studies. Infect Drug Resist, 2021, 14:1781-1794. doi:10.2147/IDR.S304864.
doi: 10.2147/IDR.S304864 URL |
[41] |
赵皎洁, 陆宇. 抗结核药物药代动力学/药效学的研究及进展. 中国防痨杂志, 2019, 41(6):700-704. doi:10.3969/j.issn.1000-6621.2019.06.020.
doi: 10.3969/j.issn.1000-6621.2019.06.020 |
[1] | Zhang Jingyi, Hu Xingyu, Gao Guangying, Chen Yingchun, Zhang Xin, Deng Qian. The inspiration of bundled payment for chronic diseases in Netherlands and the United States for tuberculosis payment reform in China [J]. Chinese Journal of Antituberculosis, 2023, 45(3): 248-252. |
[2] | Zhou Feng, Li Tongxin, Yang Song, Tang Shenjie. Progress on short-course regimens for the treatment of tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(3): 311-317. |
[3] | Qu Yunmo, Ding Xinyuan, Yan Meiyi, Guo Xiaopeng, Sun Yicheng. Development and application of CRISPR assisted genome editing technology in Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(2): 208-214. |
[4] | Shang Yuanyuan, Nie Wenjuan, Huang Hairong, Chu Naihui. Research status of drug resistance of antituberculosis drugs bedaquiline and clofazimine [J]. Chinese Journal of Antituberculosis, 2023, 45(1): 116-122. |
[5] | Wu Wenqi, Zhong Jianqiu, He Juan, Deng Guofang, Wang Qingwen. The research progress of the reactivation of latent tuberculosis infection in patients with rheumatic diseases [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 954-959. |
[6] | Chen Qiuqi, Han Tingting, Wang Qingwen, Deng Guofang. Recent advances in treatment of latent tuberculosis infection complicated with rheumatic diseases [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 960-965. |
[7] | Yao Rong, Lu Yu. Research progress on the drug resistance and mechanism of the anti-tuberculosis drug bedaquiline [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 973-977. |
[8] | Xie Fanghui, Liang Li, Zhao Xia, Yao Rong, Lei Limei, Guo Hui, Meng Meng, Wan Bin. Research progress of sputum specimen collection in patients with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 978-982. |
[9] | Liu Xiaotong, Wang Ansu, Jiang Zhongyan, Lou Yijiao, Gao Fengqiong, Feng Jiayi, Xia Tongxia. Research progress of nutrition screening and assessment tools for patients with tuberculosis [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 855-859. |
[10] | LI Yu-jie, YANG Yu-ting, YANG Guo-ping. Research progress of innate immunity and adaptive immune response in diabetic patients complicated with tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 512-516. |
[11] | YANG Ge-rile, LI Yan-mei, ZHAO Li-ping. Progress in clinical research of gastrointestinal tuberculosis and its characteristics under endoscopy [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 517-521. |
[12] | YUE Ying, HUANG Ting-ting, REN Fei, MA Jin-bao, QI Yun. Congenital drug-resistant tuberculosis: a case report and literature review [J]. Chinese Journal of Antituberculosis, 2022, 44(3): 252-257. |
[13] | FAN Ru, LI Xiao-fei. Research progress of molecular biology detection technology for tuberculosis [J]. Chinese Journal of Antituberculosis, 2022, 44(3): 294-298. |
[14] | Sheng Gang, Chu Hongqian, Liu Dingyi, Sun Zhaogang. Progress in the identification of Mycobacterium tuberculosis antigenic proteins in clinical specimens [J]. Chinese Journal of Antituberculosis, 2022, 44(12): 1363-1368. |
[15] | Tang Minghui, Li Hao. Structure and function of lipoarabinomannan and its application in tuberculosis diagnosis [J]. Chinese Journal of Antituberculosis, 2022, 44(11): 1205-1212. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||